|
Hcw Biologics Inc (NASDAQ: HCWB) |
|
Hcw Biologics Inc
HCWB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Hcw Biologics Inc 's sales fell
by -50.02 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 3152
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Hcw Biologics Inc net loss decreased from $-5 millions, to $-4 millions in III. Quarter 2024,
• More on HCWB's Growth
|
|
Hcw Biologics Inc realized a net loss in trailing twelve months.
Hcw Biologics Inc realized cash reduction of $ -0.27 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.
• More on HCWB's Valuation
|
|
|
|
|
Hcw Biologics Inc realized net loss in trailing twelve months.
Hcw Biologics Inc realized cash outflow of $ -0.27per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.
• More on HCWB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com